Sort
82,697 grants matching “vaccine development”
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
$1,310,557Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2025 · IP
Seattle-Lausanne-Kampala CTU
$1,310,445Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2018 · AI
Seattle-Lausanne-Kampala CTU
$1,310,443Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2016 · AI
Clinical Research Support for the CCR
$1,309,977Thomas A Misteli · Division Of Basic Sciences - Nci · ZID · FY2018 · CA
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of HIV Envelope Proteins
$1,309,853Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
Membrane Remodeling During Viral Infection, Parasite Invasion, And Apoptosis
$1,309,843Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE
$1,309,634Matthew Johnson · Duke University · N01 · FY2021 · AI
Characterization of Proteomes of Category A Pathogens
$1,309,441Diversa Corporation · U01 · FY2004 · AI
Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination
$1,309,318James M Binley · San Diego Biomedical Research Institute · R01 · FY2022 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,309,295Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Antigenicity and Immunogenicity of Stabilized prefusion F protein
$1,309,145Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Rapid Development of Vaccines for Emerging Viruses
$1,309,145Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Cancer Prevention-Interception Against MGUS Progression
$1,308,925Yong Li · Baylor College Of Medicine · U54 · FY2025 · CA
PEDIATRIC AIDS CLINICAL TRIALS PROGRAM
$1,308,707Baylor College Of Medicine · U01 · FY2000 · AI
Studies of Receptor Interactions and Effects of Alarmins
$1,307,824Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Early Life Vaccination to Prevent HIV acquisition during Adolescence
$1,307,799Sallie R. Permar · Duke University · P01 · FY2020 · AI
Chiang Mai University HIV/AIDS Clinical Trials Unit
$1,307,793Thira Sirisanthana · Chiang Mai University · UM1 · FY2012 · AI
Developing recombinant coronavirus vaccines for SARS
$1,307,219Xuming Zhang · Univ Of Arkansas For Med Scis · U01 · FY2007 · AI
Malaria Transmission Blocking Vaccine Discovery
$1,307,165Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
CONTROLLED RELEASE POLYMERS FOR BRAIN TUMORS (U19 CA 528
$1,306,496Johns Hopkins University · U19 · FY2004 · CA
Omics, Bioinformatics, and Data Management Core
$1,306,467Michael J Gale · Oregon Health & Science University · P01 · FY2025 · AI
Development of sG as a human vaccine against Nipah/Hendra
$1,306,446Timothy R Fouts · Profectus Biosciences, Inc. · R01 · FY2012 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,306,400Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,306,400Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP
$1,306,067John Eldridge · Profectus Biosciences, Inc. · N01 · FY2012 · AI